San Antonio study examines investigational drug for Alzheimer’s

June 6, 2006

San Antonio residents diagnosed with Alzheimer’s disease may be eligible to participate in a clinical study offered by the Health Science Center. The study will assess whether an investigational drug, Flurizan, can slow Alzheimer’s progression.


Screening method identifies unfolded, aberrant proteins

February 21, 2006

During normal aging and various neurodegenerative diseases such as Alzheimer’s, Lou Gehrig’s and Parkinson’s diseases, proteins become unfolded or clump together, thereby losing their function and damaging the cells and tissues.


Putting the proverbial brakes on aging

May 18, 2004

The University of Texas Health Science Center at San Antonio has received a $2.5 million grant for a National Institute on Aging (NIA) Intervention Testing Center, one of three such U.S. centers established by the NIA to test potential therapeutic interventions to slow the aging process.


HSC researchers seek glaucoma-Alzheimer’s link

February 17, 2004

A research group at The University of Texas Health Science Center at San Antonio is examining the intriguing possibility of a link between glaucoma and Alzheimer’s disease.